CVE-2026-92927

MEDIUMPre-NVD 5.35.3—
EchelonGraph scoreHIGH confidence

Score 5.3 from GitHub Security Advisory published 2026-09-17. a secondary CVSS source baseline 5.3; sources differ by 0.0.

Triggered by: GitHub Security Advisory CVSS
Sources: epss, ghsa, secondary
Trending — 5 sources updated this week
5.3EG
EchelonGraph verdictMonitorLow exploitation likelihood right now — keep watching.
  • Lower severity and no public exploit yet
CISA-KEV: Not listedEPSS PROB: 0%CVSS: 5.3Exploit: None knownExposed: 0

No vendor fix yet — apply a workaround or compensating control (WAF / firewall / segmentation) and watch for a patch.

A vulnerability was found in SourceCodester Drug Recommendation System 1.0. This issue affects some unknown processing of the file /db/drug_recommendor.sql. Performing a manipulation results in information disclosure. The attack is possible to be carried out remotely. The exploit has been made public and could be used.

CVSS v3
5.3
EG Score
5.3(high)
EG Risk
28(Track)
EG Risk 28/100SSVC: Track

EG Risk is EchelonGraph's 0–100 priority score: it fuses intrinsic severity with real-world exploitation and automatability so you can rank equal-severity CVEs and fix the most dangerous first. Higher = act sooner. Distinct from the 0–10 EG Score (severity).

How it’s computed
Severity53% × 45%
Exploitation0% × 40%
Automatability30% × 15%
Action: Routine — remediate on your standard cadence.
EPSS PROB
0%
EPSS %ILE
25%
KEV
Not listed

Published

September 17, 2026

Last Modified

September 17, 2026

Advisory Details (2)

Auto-updated Sep 17, 2026
No patch confirmed yet.
generic

Free Source Code Projects and Tutorials - sourcecodester.com

https://www.sourcecodester.com/
generic

Drug_recommendation_system/information_disclosure/Readme.md at main · KaranParelkar/Drug_recommendation_system · GitHub

https://github.com/KaranParelkar/Drug_recommendation_system/blob/main/information_disclosure/Readme.md

Vendor Advisories for CVE-2026-92927(1)

These vendors published their own advisory mentioning this CVE — often with vendor-specific remediation steps + affected product lists not in NVD.

Weakness Classification(2)

MITRE Common Weakness Enumeration — the root-cause categories this CVE belongs to.

Data Freshness Timeline

(refreshed 11× in last 7d / 11× in last 30d)

Each row is a source pipeline that fetched or updated this CVE on that date, with what changed. For example, "NVD update" means NVD published or revised its analysis for this CVE; "MITRE cvelistV5" means we ingested or refreshed it from the CNA feed. Most recent first.

  1. 2026-09-19 21:12 UTCEG score recompute
  2. 2026-09-19 21:11 UTCGHSA enrichment
  3. 2026-09-18 21:16 UTCEG score recompute
  4. 2026-09-18 21:16 UTCGHSA enrichment
  5. 2026-09-18 19:28 UTCEPSS rescore
  6. 2026-09-17 21:20 UTCEG score recompute
  7. 2026-09-17 21:20 UTCGHSA enrichment
  8. 2026-09-17 18:26 UTCEG score recompute
  9. 2026-09-17 18:24 UTCNVD updateCVSS v4 → 5.5
  10. 2026-09-17 17:49 UTCEG score recompute
  11. 2026-09-17 17:49 UTCMITRE cvelistV5first tracked

Related CVEs(same CWE)

Frequently asked(5)

What is CVE-2026-92927?
CVE-2026-92927 is a medium vulnerability published on September 17, 2026. A vulnerability was found in SourceCodester Drug Recommendation System 1.0. This issue affects some unknown processing of the file /db/drug_recommendor.sql. Performing a manipulation results in information disclosure. The attack is possible to be carried out remotely. The exploit has been made…
When was CVE-2026-92927 disclosed?
CVE-2026-92927 was first published in the National Vulnerability Database on September 17, 2026. EchelonGraph re-ingests CVE updates from NVD on a 2-hour cycle, so this page reflects the latest published state.
Is CVE-2026-92927 actively exploited?
CVE-2026-92927 is not currently on CISA's Known Exploited Vulnerabilities catalog. FIRST EPSS estimates a 0% probability of exploitation in the next 30 days, which ranks it in the top 75.1% of all scored CVEs.
What is the CVSS score of CVE-2026-92927?
CVE-2026-92927 has a CVSS v3 base score of 5.3 (NVD).
How do I remediate CVE-2026-92927?
Patch to the fixed version published by the affected vendor. Where vendor advisories exist for CVE-2026-92927, EchelonGraph cross-links them in the Vendor Advisories panel below — those typically contain the canonical remediation steps, fixed version numbers, and any vendor-specific mitigations.

Dependency Blast Radius

Explore the affected products and dependency analysis for CVE-2026-92927

Explore →

Is Your Infrastructure Affected by CVE-2026-92927?

EchelonGraph automatically scans your cloud infrastructure and maps CVE exposure using blast radius analysis.

Start Free Scan →Browse All CVEs